Keith Martin, MA DM MRCP FRCOphth FRANZCO FARVO
Keith Martin is Director of the Centre for Eye Research Australia and Ringland Anderson Professor and Head of Ophthalmology at the University of Melbourne. Until January 2019, he was Professor and Head of Ophthalmology at the University of Cambridge, and Deputy Director of the University’s John van Geest Centre for Brain Repair. He was also Academic Lead for Ophthalmology and Lead Clinician for Glaucoma at Cambridge University Hospital.
Professor Martin is working to develop new treatments for eye disease using gene therapy and other techniques. His other current main research interest is in regeneration and repair of the optic nerve.
He is co-founder of Quethera, a Cambridge-based gene therapy company which developed a gene therapy for glaucoma that is currently in advanced pre-clinical development by a major pharmaceutical company. He is also co-founder of Ikarovec, a second gene therapy spin out company from his Cambridge lab developing gene therapies for common retinal diseases, and Mirugen, a spin out from the Centre for Eye Research Australia developing cell reprogramming technology.
Clinically, Professor Martin specialises in the medical and surgical management of complex glaucoma. He was President of the World Glaucoma Association from 2018-20, is a Past President of the UK and Ireland Glaucoma Society, and is currently Chair of the Australia and New Zealand Glaucoma Society.